Skip to content
verana-health-logo-inverted
  • Clinicians
    • MIPS Advisory Offerings
    • Practice Insights
    • Verana Trial Connect
    • Verana Quality Measures
  • Life Sciences
    • Clinical Development
    • HEOR & Medical Affairs
    • Commercialization
  • Research
  • Therapeutic Area
    • Oncology
      • Acute Myeloid Leukemia
      • Breast Cancer
      • Chronic Lymphocytic Leukemia
      • Colorectal Cancer
      • Follicular Lymphoma
      • Large B-Cell Lymphoma
      • Lung Cancer
      • Marginal Zone Lymphoma
      • Melanoma
      • Multiple Myeloma
      • Myelodysplastic Syndrome
      • Ovarian Cancer
    • Ophthalmology
      • Anti-VEGF
      • Diabetic Retinopathy
      • Dry Eye Disease
      • Cataracts
      • Geographic Atrophy
      • Glaucoma
      • Neovascular AMD
      • Retinitis Pigmentosa
      • Thyroid Eye Disease
      • Uveitic Macular Edema
      • Qdata Explorer
    • Urology
      • Benign Prostatic Hyperplasia
      • Bladder Cancer
      • Prostate Cancer
    • Neurology
      • Multiple Sclerosis
      • Parkinson’s Disease
      • Spinal Muscular Atrophy
  • Solutions
    • Clinical Research Solutions
      • Trial Design
      • Protocol Optimization & Site Selection
      • Patient Recruitment
      • Prospective Evidence Generation (PEG)
    • Clinical Trials
      • Site Explorer
    • Market Insights
      • Market Tracking
      • Brand Switching
      • Prescriber Mapping
    • RWE Studies
      • Patient Segmentation
      • Safety Studies
      • Natural History of Disease / Disease Progression
      • Comparative Effectiveness
      • Treatment Patterns & Outcomes
      • Healthcare Resource Utilization (HCRU) Cost
    • Phase IV Studies / Surveillance
  • About Us
    • About
      • Evolve Registry
    • Team
    • Press
    • Blog
    • Careers
    • Partners
      • Societies
      • CROs
      • Technology and Data
    • Privacy
      • Privacy Policy
      • Patient Privacy
Contact Us

Press

Verana Health Announces Launch of Qdata® Uveitic Macular Edema Module

May 30, 2024
Read More...

RWC 2024: An Overview of Real World Geographic Atrophy Data

May 24, 2024
Read More...

Value of Real-World Insights in Ophthalmology and GA Treatment

May 22, 2024
Read More...

Managing Concurrent Wet AMD and GA

May 20, 2024
Read More...

20 Business Leaders Share The Key To Finding Joy In Business Ownership

April 24, 2024
Read More...

Verana Health Launches its Qdata Thyroid Eye Disease Module

April 24, 2024
Read More...

Verana Health Announces Launch of Qdata® Thyroid Eye Disease

April 24, 2024
Read More...

20 Essential Steps For Ethically Leveraging AI In Your Business

April 19, 2024
Read More...

Verana Health to Reveal Results from Largest Pediatric Intraocular Lens Study, Funded by the FDA, During AAPOS 2024

April 9, 2024
Read More...

The Value of Real-World Insights in Ophthalmology and Geographic Atrophy (GA) Treatment

April 5, 2024
Read More...
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 25
  • Next »
verana-health-logo-inverted

© 2026 Verana Health. All Rights Reserved.

San Francisco
New York
Knoxville
  • Privacy Policy
  • Cookie Policy
Back to Top